Sigmacare Pharma · Paediatric Formulation
Lansoprazole 15mg Orally Disintegrating Tablets
Safe & Effective to Treat GERD in Kids
Well tolerated in neonates & infants under 1 year of age with gastroesophageal reflux disease (GERD) associated with symptoms.
Clinically proven: 80% of children with GERD were symptom-free at Week 12 when treated with Lansoprazole 15–30mg QD-BID for 8–12 weeks.
100% healing rate for Erosive Esophagitis at Week 12 in children (Grade >2) treated with Lansoprazole 15–30mg QD-BID for 8–12 weeks.
Orally disintegrating tablet formulation — easy to administer for young children without the need for water.
Ref: J Pediatr Gastroenterol Nutr 2002; 35 (suppl. 4): S308 | Paediatr Drugs 2008;10(4):225-43.
